Lanean...
Emerging treatments in management of prostate cancer: biomarker validation and endpoints for immunotherapy clinical trial design
The rapidly emerging field of immunotherapy and the development of novel immunologic agents that have been approved in melanoma and successfully studied in lung cancer, kidney cancer, and prostate cancer have mandated that there be uniformity in clinical trial analysis beyond conventional survival e...
Gorde:
| Argitaratua izan da: | Immunotargets Ther |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Dove Medical Press
2013
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4918229/ https://ncbi.nlm.nih.gov/pubmed/27471695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/ITT.S30821 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|